Effects of sulfhydryl compounds on interleukin-1-induced vascular endothelial growth factor production in human synovial stromal cells

Citation
F. Tsuji et al., Effects of sulfhydryl compounds on interleukin-1-induced vascular endothelial growth factor production in human synovial stromal cells, BIOL PHAR B, 23(5), 2000, pp. 663-665
Citations number
17
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOLOGICAL & PHARMACEUTICAL BULLETIN
ISSN journal
09186158 → ACNP
Volume
23
Issue
5
Year of publication
2000
Pages
663 - 665
Database
ISI
SICI code
0918-6158(200005)23:5<663:EOSCOI>2.0.ZU;2-I
Abstract
We investigated the effects of various sulfhydryl compounds on interleukin- 1 (IL-1)-induced vascular endothelial growth factor (VEGF) production in hu man synovial stromal cells (HSSC). HSSC stimulated by IL-1 beta (100 ng/ml) produced VEGF and interleukin-6 (IL-6) in vitro, Monosulfhydryl compounds, N-acetylcysteine, D-penicillamine, tiopronin and the bucillamine-like disu lfhydryl compound, compound A scarcely affected VEGF or IL-6 production at concentrations of 10(-5) and 10(-4) M. However, the disulfhydryl compound, bucillamine inhibited VEGF production but not IL-6 production at concentrat ions of 10(-5) and 10(-4) M. These results suggest that bucillamine may be a selective inhibitor of IL-1-induced VEGF production in HSSC, and that inh ibition of VEGF production may require not only SH groups but also a specif ic chemical structure.